Cells from the patient's fat are cultured for administration. The clinic describes skin injections and chronic-pain infusions; eligibility and evidence are indication-specific. Indicative targets include pain lasting or recurring beyond three months, or continuing more than a month after its cause has healed.
Risks & considerationsDiscuss collection/injection pain, bleeding, infection and fever. Autologous does not mean risk-free; confirm processing controls and emergency arrangements.
Blood is drawn and processed to separate platelet-rich plasma for injection. This does not involve culturing stem cells; preparation and volume matter.
Risks & considerationsBruising, redness, swelling and pigmentation are possible. Disclose anticoagulants, bleeding disorders, pregnancy, cancer and immune conditions; do not stop medicines yourself.
Supernatant contains substances released during cell culture; exosomes are small cell-released vesicles. These are not synonyms or living stem-cell treatment. The official page describes a concentrated culture supernatant containing growth factors such as EGF, IGF, TGF-β, PDGF, HGF, VEGF and KGF.
Risks & considerationsDiscuss pain, swelling, bruising, allergy and infection. A July 2024 MHLW notice reported no approved medicines of this kind and highlighted safety concerns and uncertainty. The official page notes the products are cultured in serum-free media and have undergone safety tests including intradermal reaction, toxicity and antigenicity.
